Background This systematic review provides updated insights, from the published literature
in the past 5 years, based on the 2017 European Association of Neuro-Oncology (EANO) …

Gliomas represent the majority of malignant central nervous system tumors, with the most
aggressive subtype, glioblastoma, accounting for almost 57% of this entity. Type of glioma …

It is critical for patients with hematologic malignancies to have an accurate understanding of
their illness and prognosis to make informed treatment decisions. Illness and prognostic …

Background: Patients with glioblastoma have a poor prognosis and treatment is palliative in
nature from diagnosis. It is therefore critical that the benefits and burdens of treatments are …

High-grade glioma (HGG) is characterized by debilitating neurologic symptoms and poor
prognosis. Some of the suffering this disease engenders may be ameliorated through …

Aims The associations between prognostic awareness, acceptance of illness and
psychological outcomes (anxiety, depression and spiritual well-being) remain unclear. This …

Purpose Discordant prognostic awareness (PA) can cause distress, impact goals of care
and future planning, especially in patients with high grade glioma (pwHGG) who have …

Objective Malignant glioma (MG) is a devastating neuro‐oncologic disease with almost
invariably poor prognosis, yet many families facing malignant glioma have poor prognostic …

Background: Prognostic awareness (PA)—the understanding of limited life expectancy—is
critical for effective goals of care discussions (GOCD) in which patients discuss their goals …

Purpose Glioblastoma (GBM) is a devastating neuro-oncologic disease with invariably poor
prognosis. Despite this, research shows patients have unrealistic perceptions of their …